SG3 Management’s QuidelOrtho QDEL Stock Holding History

SG3 Management’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,000	Closed	-$257K	–	136
2022 Q4	$257K	Buy	+3,000	New	+$254K	0.04%	150
2021 Q1	–	Sell	-10,000	Closed	-$1.8M	–	1406
2020 Q4	$1.8M	Sell	10,000 -4,999	-33%	-$1.11M	0.03%	415
2020 Q3	$3.29M	Sell	14,999 -10,001	-40%	-$2.23M	0.12%	191
2020 Q2	$5.59M	Buy	+25,000	New	+$3.92M	0.39%	57
2018 Q4	–	Sell	-4,000	Closed	-$261K	–	241
2018 Q3	$261K	Buy	+4,000	New	+$280K	0.04%	120

Other funds holding QDEL

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

SG3 Management's QDEL Position: Q1 2023 in Review

SG3 Management sold out of QuidelOrtho (QDEL) in Q1 2023, closing a stake of 3,000 shares — an estimated $257K sold.

SG3 Management first reported a position in QDEL in Q3 2018 and held it in 5 quarters. The position peaked at $5.59M in Q2 2020. 332 funds tracked by Wall St. Rank hold QDEL as of Q1 2023.

SG3 Management reported no remaining QuidelOrtho position as of Q1 2023 after selling out during the quarter.
SG3 Management sold 3,000 QuidelOrtho shares in Q1 2023, an estimated $257K.
SG3 Management first reported a position in QuidelOrtho in Q3 2018 and held it in 5 quarters.
SG3 Management's QuidelOrtho position peaked at $5.59M in Q2 2020.
332 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2023.

Based on SG3 Management's 13F filing for Q1 2023, filed 15 May 2023.